Published in Am J Transplant on September 01, 2002
Candidacy for kidney transplantation of older adults. J Am Geriatr Soc (2012) 1.85
Listing for expanded criteria donor kidneys in older adults and those with predicted benefit. Am J Transplant (2010) 1.65
Availability, utilization and outcomes of deceased diabetic donor kidneys; analysis based on the UNOS registry. Am J Transplant (2012) 1.52
Development of organ-specific donor risk indices. Liver Transpl (2012) 1.26
Contribution of large pig for renal ischemia-reperfusion and transplantation studies: the preclinical model. J Biomed Biotechnol (2011) 1.26
OSAKA trial: a randomized, controlled trial comparing tacrolimus QD and BD in kidney transplantation. Transplantation (2013) 1.14
Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant. Ann Surg (2004) 1.04
Deceased donor renal transplantation at army hospital research and referral: Our experience. Indian J Urol (2013) 1.01
Organ donation after acute brain death: addressing limitations of time and resources in the emergency department. Yale J Biol Med (2013) 0.91
The blockade of T-cell co-stimulation as a therapeutic stratagem for immunosuppression: Focus on belatacept. Biologics (2007) 0.87
Outcome of expanded criteria donor kidneys that were transplanted at other Eurotransplant centers after being rejected by our institution. World J Urol (2012) 0.87
One life ends, another begins: Management of a brain-dead pregnant mother-A systematic review-. BMC Med (2010) 0.86
Efficient utilization of the expanded criteria donor (ECD) deceased donor kidney pool: an analysis of the effect of labeling. Am J Transplant (2010) 0.84
Interest of low-dose hydrocortisone therapy during brain-dead organ donor resuscitation: the CORTICOME study. Crit Care (2014) 0.83
Urinary CD133+ extracellular vesicles are decreased in kidney transplanted patients with slow graft function and vascular damage. PLoS One (2014) 0.82
Age and the allocation of organs for transplantation: a case study. Health Care Anal (2005) 0.82
Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study. Am J Transplant (2016) 0.82
Guidelines for the assessment and acceptance of potential brain-dead organ donors. Rev Bras Ter Intensiva (2016) 0.81
Primary Cardiac Allograft Dysfunction-Validation of a Clinical Definition. Transplantation (2015) 0.78
Neutrophil Gelatinase Associated Lipocalin Is an Early and Accurate Biomarker of Graft Function and Tissue Regeneration in Kidney Transplantation from Extended Criteria Donors. PLoS One (2015) 0.77
Recipient-matching of Passenger Leukocytes Prolongs Survival of Donor Lung Allografts in Miniature Swine. Transplantation (2015) 0.77
Long-Term Outcomes and Discard Rate of Kidneys by Decade of Extended Criteria Donor Age. Clin J Am Soc Nephrol (2016) 0.75
Inhibition of complement improves graft outcome in a pig model of kidney autotransplantation. J Transl Med (2016) 0.75
"Age" in lung transplantation: factors related to outcomes and other considerations. Curr Pulmonol Rep (2016) 0.75
Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors. World J Gastroenterol (2017) 0.75
Trends in Usage and Outcomes for Expanded Criteria Donor Kidney Transplantation in the United States Characterized by Kidney Donor Profile Index. Cureus (2016) 0.75
Influence of specific thoracic donor therapy on kidney donation and long-term kidney graft survival. J Nephrol (2016) 0.75
Fifteen-Year Analysis of Deceased Kidney Donation: A Single Transplant Center Experience in a Region of Northern Italy. Med Sci Monit (2017) 0.75
Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology (2003) 10.11
Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med (2003) 8.47
Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med (2006) 5.42
Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function. N Engl J Med (2015) 5.12
The survival benefit of liver transplantation. Am J Transplant (2005) 5.08
Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2008) 4.72
A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation (2009) 4.45
Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology (2008) 4.26
Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA (2005) 4.16
Effect of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups. N Engl J Med (2004) 3.96
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2015) 3.94
Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int (2003) 3.90
Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol (2006) 3.84
Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients. Transplantation (2007) 3.69
Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int (2005) 3.56
Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol (2003) 3.53
Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation (2002) 3.42
Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2004) 3.37
IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest (2007) 3.31
Standing the test of time: outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment. Hepatology (2014) 3.29
Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol (2004) 3.27
The ethics statement of the Vancouver Forum on the live lung, liver, pancreas, and intestine donor. Transplantation (2006) 3.24
Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2006) 3.21
Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria. Liver Transpl (2014) 3.11
Dialysis outcomes and analysis of practice patterns suggests the dialysis schedule affects day-of-week mortality. Kidney Int (2012) 3.02
Donor and recipient outcomes in right lobe adult living donor liver transplantation. Liver Transpl (2002) 2.98
Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg (2009) 2.95
Morbidity and mortality after living kidney donation, 1999-2001: survey of United States transplant centers. Am J Transplant (2003) 2.95
Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis (2009) 2.93
Hepatic ischemia/reperfusion injury--a fresh look. Exp Mol Pathol (2003) 2.81
Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology (2007) 2.72
Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int (2003) 2.65
Case records of the Massachusetts General Hospital. Case 15-2009. A 25-year-old man with coma after cardiac arrest. N Engl J Med (2009) 2.65
Revisiting survival differences by race and ethnicity among hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study. J Am Soc Nephrol (2006) 2.65
Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg (2005) 2.64
Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology (2005) 2.63
Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening. Cancer Cell (2011) 2.56
A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl (2005) 2.56
A report of the Vancouver Forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines. Transplantation (2006) 2.55
ASC/caspase-1/IL-1β signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury. Hepatology (2013) 2.45
Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation (2005) 2.36
Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma. Liver Transpl (2012) 2.32
Blockade of Janus kinase-2 signaling ameliorates mouse liver damage due to ischemia and reperfusion. Liver Transpl (2010) 2.30
Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2008) 2.30
Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl (2002) 2.28
Expanded criteria donors for kidney transplantation. Am J Transplant (2003) 2.25
Rates of solid-organ wait-listing, transplantation, and survival among residents of rural and urban areas. JAMA (2008) 2.24
Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int (2002) 2.24
Incisional hernia after liver transplantation. J Am Coll Surg (2006) 2.23
High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death. Kidney Int (2008) 2.22
Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients. J Am Soc Nephrol (2010) 2.22
Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS One (2010) 2.19
Surgical privileging and credentialing: a report of a discussion and study group of the American Surgical Association. J Am Coll Surg (2009) 2.18
Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients. J Am Coll Surg (2009) 2.16
Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int (2002) 2.16
Changes in dialysis treatment modalities during institution of flat rate reimbursement and quality assurance programs. Kidney Int (2013) 2.14
Improving liver allocation: MELD and PELD. Am J Transplant (2004) 2.14
Liver transplantation in highest acuity recipients: identifying factors to avoid futility. Ann Surg (2014) 2.13
Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation. Transplantation (2015) 2.13
Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg (2007) 2.12
Interobserver variability in grading transbronchial lung biopsy specimens after lung transplantation. Chest (2013) 2.09
Developmental context determines latency of MYC-induced tumorigenesis. PLoS Biol (2004) 2.05
Predictors of left ventricular regional wall motion abnormalities after subarachnoid hemorrhage. Neurocrit Care (2006) 2.05
Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study. Am J Kidney Dis (2005) 2.05
Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology (2005) 2.04
An examination of liver offers to candidates on the liver transplant wait-list. Gastroenterology (2012) 2.03
Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl (2002) 2.03
Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology (2011) 2.01
Procurement of liver and pancreas allografts in donors with replaced/accessory right hepatic arteries. Transplantation (2004) 2.01
Surgery for hepatocellular carcinoma: does it improve survival? Ann Surg Oncol (2004) 2.01
National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant (2004) 2.01
Insurance type and minority status associated with large disparities in prelisting dialysis among candidates for kidney transplantation. Clin J Am Soc Nephrol (2008) 1.98
Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol (2009) 1.97
Racial and ethnic disparities in access to liver transplantation. Liver Transpl (2010) 1.94
Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2004) 1.93
Living-donor kidney transplantation: a review of the current practices for the live donor. J Am Soc Nephrol (2005) 1.93
Association of center volume with outcome after liver and kidney transplantation. Am J Transplant (2004) 1.92
Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant (2002) 1.92
Managing the prevention of retained surgical instruments: what is the value of counting? Ann Surg (2008) 1.92
Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology (2014) 1.91